stockrow
Friday 6 November 2026
Export HCM’s income statement to Excel — free account
HUTCHMED (China) Limited Sponsored ADR
HCM Healthcare Drug Manufacturers Specialty & Generic
HUTCHMED (China) Limited Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $548.5 million, down 13.0% from fiscal 2024.
15.19
0.99
+6.97%
Follow HCM
Alert me
| Older periods | Dec '24 | Jun '25 | Dec '25 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
2.68 | 4.48 | 4.80 | 5.50 | |
Current Ratio |
2.83 | 4.65 | 4.96 | 5.64 | |
Net Debt/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
Debt/Assets |
6.50% | 5.26% | 5.31% | 5.44% | |
Debt/Equity |
0.11 | 0.08 | 0.07 | 0.07 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
(1.45) | (1.51) | (1.06) | (0.80) | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
— | 0.00% | — | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Operating CF per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Cash per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Shareholders Equity per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow |
(17.44) | (82.15) | (78.78) | 6.60 | |
Working Capital |
689.99 | 1,249.98 | 1,251.57 | 1,278.20 | |
Capital Expenditures |
(17.93) | (9.26) | (14.12) | (5.62) | |
Net Current Asset Value |
564.21 | 1,058.31 | 1,065.51 | 1,091.95 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
161.68 | 163.47 | 140.15 | 154.69 | |
Average Payables |
56.82 | 49.15 | 40.93 | 163.13 | |
Average Inventory |
53.55 | 51.16 | 45.69 | 43.64 | |
Average Assets |
1,151.82 | 1,536.72 | 1,516.44 | 1,498.65 | |
Average Common Equity |
704.36 | 1,020.97 | 997.32 | 1,013.49 |
Columns are period end dates